Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS.DL)

CAPS Rating: No stars

A biopharmaceutical company committed to the discovery, development and commercialization of small-molecule medicines for the treatment of hepatitis and cancer.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

1 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ANDS.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

msim12 (94.26)
Submitted March 09, 2011

Fund buying. Bounce from all time lows. Offering done at 1.8 Have enough liquidity. Real life started at 95 cents and out at around 1.30 Will trade in and out in real life, but will probably leave the pick here for at least 6 months.

quinpeung (33.78)
Submitted January 06, 2011

Just initiated a Phase IIb study. Outside of a partnership deal, no positive stimulus is envioned for the near future. And big pharma will be less inclined in coming years to gamble on biotechs before the Phase 3 results are in hand. The stock, whose… More

NASDAQ:ANDS.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about ANDS.DL.

No one has written a Pitch for ANDS.DL stock yet. Tell us why you think ANDS.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in ANDS.DL.

Score Leader

delmarabu

delmarabu (< 20) Score: +469.65

The Score Leader is the player with the highest score across all their picks in ANDS.DL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
DMBonedust 68.69 9/2/2020 Outperform 5Y $3.70 0% +19.20% -19.20 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ANDS.DL.